Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pancreatic neuroendocrine tumour metastatic
ADR ID BADD_A09001
ADR Hierarchy
05      Endocrine disorders
05.08      Neoplastic and ectopic endocrinopathies
05.08.01      Endocrine neoplasms NEC
05.08.01.015      Pancreatic neuroendocrine tumour metastatic
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.09      Pancreatic neoplasms
07.21.09.010      Pancreatic neuroendocrine tumour metastatic
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.24      Endocrine neoplasms malignant and unspecified
16.24.02      Islet cell neoplasms and APUDoma NEC
16.24.02.006      Pancreatic neuroendocrine tumour metastatic
Description Not Available
MedDRA Code 10068909
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Pancreatic neuroendocrine tumour metastatic | Pancreatic neuroendocrine tumor metastatic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00858Everolimus0.000306%
BADD_D02029Sitagliptin0.000053%
BADD_D02100Sunitinib0.000112%
BADD_D02568Lutetium oxodotreotide lu-177-
The 1th Page    1    Total 1 Pages